Amanda Mathew, Ph.D.
Smoking Cessation Program Specifically Designed for COPD Patients
Chronic obstructive pulmonary disease (COPD) is caused primarily by smoking, and smoking cessation is the first-line treatment for slowing disease progression. Smokers with COPD report high rates of co-occurring conditions—nicotine dependence, depression, and anxiety—which are barriers to quitting. There is limited understanding of the psychological risk factors that commonly drive these conditions and how they can be addressed through targeted behavioral treatment. We will develop a novel smoking cessation intervention among COPD patients and use data from patients and providers to guide treatment delivery. Findings will guide a randomized, controlled trial to test an intervention with important implications for improving behavioral health and reducing morbidity and mortality among COPD patients.